New England Research & Management, Inc.

Position in GILD — Gilead Sciences, Inc.

CIK 1596077 CHICAGO, IL

Position in GILD

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$2,661,983

+$1,119,158 QoQ

Shares Held

21,070

+90.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

1.05%

of 13F equity value

Holder Rank

#747

of 2,266 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

New England Research & Management, Inc. holds $31,997,185 across 8 Drug Manufacturers - General names. GILD ranks #7 (8.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	29,527	$7,498,972
2	ABBV	AbbVie Inc.	24,774	$6,234,129
3	AMGN	Amgen Inc	11,880	$4,301,985
4	LLY	ELI LILLY & Co	3,556	$4,265,173
5	MRK	Merck & Co., Inc.	27,279	$3,505,351
6	AZN	Astrazeneca PLC	15,893	$3,013,630
7	GILD	Gilead Sciences, Inc. This page	21,070	$2,661,983
8	PFE	Pfizer Inc	21,427	$515,962

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,661,983	21,070	+90.3%	Shares	Sole	2026-07-09
2026-03-31	$1,542,825	11,070	-5.4%	Shares	Sole	2026-05-07
2025-12-31	$1,436,058	11,700	+143.8%	Shares	Sole	2026-01-07
2024-09-30	$402,432	4,800	-10.9%	Shares	Sole	2024-10-07
2024-06-30	$369,602	5,387	-68.0%	Shares	Sole	2024-07-09
2024-03-31	$1,232,431	16,825	+204.5%	Shares	Sole	2024-04-16
2023-12-31	$447,580	5,525	-55.3%	Shares	Sole	2024-02-06
2022-06-30	$763,353	12,350	+128.3%	Shares	Sole	2022-07-20
2020-06-30	$416,245	5,410	+71.2%	Shares	Sole	2020-07-15
2020-03-31	$236,241	3,160	—	Shares	Sole	2020-06-15
No filing history on record for this holder in this stock.